Healthcare · NIFTY 500
Torrent Pharmaceuticals Limited
NSETORNTPHARM
BSE500420 ISININE685A01028 SeriesEQ Listed on NSE · BSE
₹4,727.20 -33.80 (-0.71%) Updated 12 Nov, 8:49 pm IST
Price, daily close+32.87% in a year
Today
- Open
- ₹4,761.00
- Prev close
- ₹4,761.00
- Day high
- ₹4,765.10
- Day low
- ₹4,660.00
- Volume
- 2.85 L
- Value traded
- ₹134.36 Cr
- Upper circuit
- ₹4,842.70
- Lower circuit
- ₹4,560.70
- 52W high
- ₹5,250.00
- 52W low
- ₹3,532.60
- 1 month
- +2.88%
- 6 months
- +5.16%
52W low52W high
Ratios
Key numbers
Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.
Market cap₹179,804 Cr
P/E (TTM)79.85
P/B9.79
Book value / share₹483.04
EPS (TTM)₹59.20
ROE11.6%
Dividend yield0.80%
Dividend (12m)₹38.00 / share
Net margin (TTM)12.2%
Operating margin33.3%
Debt / equity0.76
Current ratio1.32
EV / EBITDA34.02
Sales growth (YoY qtr)+50.79%
Profit growth (YoY qtr)-9.64%
Sales CAGR 3Y+13.27%
Profit CAGR 3Y+20.22%
Shares38.04 Cr
Quarterly results
Results for each quarter
Last 12 quarters, consolidated, ₹ crore. Hover a bar to see the number.
Revenue and net profit
Dec 23
Mar 24
Jun 24
Sep 24
Dec 24
Mar 25
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
Revenue · QoQ (vs last quarter)
—+0.5%+4.2%+1.0%-2.8%+5.3%+7.4%+3.9%+0.0%+27%+17%+1.2%
Revenue · YoY (vs a year ago)
————+2.8%+7.8%+11%+14%+18%+42%+55%+51%
Net profit · QoQ (vs last quarter)
—+1.6%+1.8%-0.9%+11%-1.0%+10%+7.8%+7.4%-39%+46%-5.7%
Net profit · YoY (vs a year ago)
————+14%+11%+20%+30%+26%-22%+3.3%-9.6%
RevenueNet profitLine = trend
Dec 23
Mar 24
Jun 24
Sep 24
Dec 24
Mar 25
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
EPS (₹) · YoY (vs a year ago)
————+14%+11%+20%+31%+26%-22%-8.2%-19%
EPS (₹)Line = trend
| ₹ Cr | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,732 | 2,745 | 2,859 | 2,889 | 2,809 | 2,959 | 3,178 | 3,302 | 3,303 | 4,197 | 4,921 | 4,979 |
| Other income | -33.0 | 31.0 | 24.0 | -16.0 | 33.0 | -18.0 | -37.0 | -27.0 | -13.0 | -17.0 | -12.0 | -10.0 |
| Total income | 2,699 | 2,776 | 2,883 | 2,873 | 2,842 | 2,941 | 3,141 | 3,275 | 3,290 | 4,180 | 4,909 | 4,969 |
| Raw material | 379 | 410 | 411 | 337 | 370 | 402 | 396 | 382 | 414 | 566 | 609 | 588 |
| Purchases | 327 | 315 | 313 | 382 | 420 | 416 | 338 | 382 | 422 | 477 | 531 | 593 |
| Employee cost | 496 | 486 | 550 | 543 | 549 | 561 | 605 | 627 | 651 | 788 | 893 | 895 |
| Other expenses | 670 | 697 | 711 | 729 | 673 | 703 | 767 | 792 | 765 | 1,038 | 1,201 | 1,194 |
| Total expenses | 2,156 | 2,145 | 2,227 | 2,212 | 2,151 | 2,252 | 2,403 | 2,471 | 2,466 | 3,585 | 4,155 | 4,222 |
| Operating profit | 957 | 883 | 904 | 939 | 914 | 940 | 1,032 | 1,070 | 1,078 | 1,290 | 1,643 | 1,656 |
| OPM % | 35.0% | 32.2% | 31.6% | 32.5% | 32.5% | 31.8% | 32.5% | 32.4% | 32.6% | 30.7% | 33.4% | 33.3% |
| Finance cost | 80.0 | 80.0 | 75.0 | 64.0 | 57.0 | 56.0 | 56.0 | 48.0 | 45.0 | 236 | 305 | 300 |
| Depreciation | 213 | 203 | 197 | 198 | 199 | 201 | 201 | 204 | 206 | 508 | 593 | 609 |
| Exceptional items | 88.0 | — | — | — | — | -24.0 | — | -13.0 | -10.0 | -66.0 | -21.0 | -10.0 |
| Profit before tax | 631 | 631 | 656 | 661 | 691 | 665 | 738 | 791 | 814 | 529 | 733 | 737 |
| Tax | 188 | 182 | 199 | 208 | 188 | 167 | 190 | 200 | 179 | 165 | 167 | 203 |
| Net profit | 443 | 449 | 457 | 453 | 503 | 498 | 548 | 591 | 635 | 364 | 566 | 534 |
| Profit to shareholders | 442 | 449 | 457 | — | — | 498 | 548 | 591 | 635 | 389 | 566 | 534 |
| EPS (₹) | 13.10 | 13.27 | 13.51 | 13.37 | 14.88 | 14.71 | 16.19 | 17.45 | 18.77 | 11.51 | 14.87 | 14.05 |
Profit & loss
Results for each year
8 financial years (April to March), consolidated, ₹ crore.
Sales, operating profit and net profit
FY19
FY20
FY21
FY22
FY23
FY24
FY25
FY26
Revenue · YoY (vs a year ago)
—+3.5%+0.8%+6.3%+13%+12%+7.3%+21%
Net profit · YoY (vs a year ago)
—+135%+22%-38%+60%+33%+15%+13%
RevenueOperating profitNet profitLine = trend
| ₹ Cr | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7,673 | 7,939 | 8,005 | 8,508 | 9,620 | 10,728 | 11,516 | 13,980 |
| Other income | 57.0 | 122 | 57.0 | 197 | 45.0 | 58.0 | 23.0 | -94.0 |
| Total expenses | 6,811 | 6,874 | 6,536 | 6,994 | 7,818 | 8,522 | 8,842 | 10,925 |
| Employee cost | 1,404 | 1,429 | 1,440 | 1,526 | 1,678 | 1,984 | 2,203 | 2,671 |
| Operating profit | 1,627 | 2,170 | 2,485 | 1,946 | 2,842 | 3,456 | 3,697 | 4,470 |
| OPM % | 21.2% | 27.3% | 31.0% | 22.9% | 29.5% | 32.2% | 32.1% | 32.0% |
| Finance cost | 504 | 451 | 358 | 255 | 333 | 354 | 252 | 385 |
| Depreciation | 618 | 654 | 658 | 662 | 707 | 808 | 795 | 1,119 |
| Profit before tax | 562 | 1,187 | 1,526 | 1,226 | 1,847 | 2,352 | 2,673 | 2,872 |
| Tax | 126 | 162 | 274 | 449 | 602 | 696 | 762 | 734 |
| Tax rate % | 22.4% | 13.6% | 18.0% | 36.6% | 32.6% | 29.6% | 28.5% | 25.6% |
| Net profit | 436 | 1,025 | 1,252 | 777 | 1,245 | 1,656 | 1,911 | 2,138 |
| Profit to shareholders | — | — | 1,252 | 777 | 1,245 | 1,656 | 1,911 | 2,163 |
| Net margin % | 5.7% | 12.9% | 15.6% | 9.1% | 12.9% | 15.4% | 16.6% | 15.5% |
| EPS (₹) | 25.78 | 60.55 | 73.98 | 0.00 | 36.79 | 48.94 | 56.47 | 63.92 |
Balance sheet
Assets and debt
At each year end (and the latest half year), ₹ crore.
Equity, debt and assets
Mar 23
Mar 24
Mar 25
Mar 26
Sep 26
Shareholders' equity · YoY (vs a year ago)
—+11%+11%+11%—
Shareholders' equityBorrowingsCashLine = trend
| ₹ Cr | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Sep 26 |
|---|---|---|---|---|---|
| Shareholders' equity | 6,198 | 6,856 | 7,591 | 8,389 | 18,373 |
| Long-term borrowings | 2,496 | 1,604 | 1,192 | 11,651 | 11,620 |
| Short-term borrowings | 2,801 | 2,334 | 1,834 | 3,147 | 2,254 |
| Total borrowings | 5,297 | 3,938 | 3,026 | 14,798 | 13,874 |
| Current liabilities | 5,447 | 5,426 | 4,717 | 8,343 | 7,984 |
| Fixed assets (PPE) | 2,772 | 3,297 | 3,455 | 4,909 | 5,066 |
| Inventories | 2,230 | 2,279 | 2,541 | 3,138 | 3,182 |
| Trade receivables | 1,944 | 1,844 | 1,867 | 3,031 | 3,398 |
| Cash & equivalents | 508 | 835 | 573 | 1,117 | 891 |
| Current assets | 5,314 | 5,611 | 5,623 | 9,392 | 10,517 |
| Total assets | 15,012 | 15,061 | 14,990 | 44,312 | 44,615 |
| Debt / equity | 0.85 | 0.57 | 0.40 | 1.76 | 0.76 |
Cash flow
Cash coming in and going out
For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.
Operating, investing and financing cash
FY22
FY23
FY24
FY25
FY26
Operations · YoY (vs a year ago)
—+31%+38%-21%+17%
OperationsInvestingFinancingLine = trend
| ₹ Cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 1,803 | 2,368 | 3,266 | 2,585 | 3,023 |
| Cash from investing | -198 | -2,356 | -168 | -540 | -12,713 |
| Cash from financing | -1,781 | 77.0 | -2,779 | -2,298 | 10,151 |
| Spent on fixed assets | -203 | -574 | -433 | -611 | -677 |
| Free cash flow | 1,600 | 1,794 | 2,833 | 1,974 | 2,346 |
| Net cash flow | -176 | 89.0 | 319 | -253 | 461 |
Shareholding
Who holds the shares
Promoter and public holding at each quarter end, as filed with NSE.
Holding over time
Promoter & groupPublic
Latest (30 Sep 2026)
60.8%promoter
- Promoter & group
- 60.78%
- Public (FIIs, mutual funds, retail…)
- 39.22%
- Promoter change, last quarter
- 0.00 pts
Dividends & news
Latest dividends and announcements
Dividends & corporate actions
- Dividend - Rs 9 Per Share
- Interim Dividend - Rs 29 Per Share
- Dividend - Rs 6 Per Share
- Interim Dividend - Rs 26 Per Sh
- Dividend - Rs 6 Per Share
- Interim Dividend - Rs 22 Per Share
- Dividend - Rs 8 Per Share
- Interim Dividend - Rs 14 Per Share
Board meetings
- the Half Yearly Audited Financial results of the Company for the period ended September 2026 and Other business.
- the Half Yearly Audited Financial results of the Company for the period ended September 2026 and Other business.
- the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the …
- other business matters
- the Quarterly Unaudited Financial results of the Company for the period ended June 2026 and Other business.
Filings with NSE
- Analysts/Institutional Investor Meet/Con. Call Updates
- General Updates
- General Updates
- Copy of Newspaper Publication
- Analysts/Institutional Investor Meet/Con. Call Updates
- Analysts/Institutional Investor Meet/Con. Call Updates
- Press Release
Latest news
TORNTPHARM Share Price Today - Torrent Pharmaceuticals on NSE/BSEscanx.trade · 9 Nov, 3:53 amTorrent Pharma Standalone September 2026 Net Sales at Rs 4,145.00 crore, up 50.07% Y-o-YMoneycontrol.com · 12 Nov, 2:33 pmTorrent Pharma Allots 4.19 Crore Shares After JB Chemicals MergerHDFC Sky · 21 Jul, 12:30 pmTorrent Pharma rises 5% on Q4 beat; brokerages divided on JBCP integrationBusiness Standard · 25 May, 12:30 pmTorrent Pharmaceuticals Shares Fall 2.08%TradingView · 16 Jul, 12:30 pmTorrent Pharma shares soar 6% to 52-week high post Q3 results, dividend declared; check numbersUpstox · 16 Feb, 1:30 pmTorrent Pharmaceuticals shares gain over 2% in today's tradeMoneycontrol.com · 18 Aug, 12:30 pmTorrent Pharma share price jumps 6% to hit a record high— Is it a stock to buy, sell or hold after Q3 results?Livemint · 16 Feb, 1:30 pmAbout
About Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Ltd, d/b/a Torrent Pharma, is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.
From Wikipedia (CC BY-SA 4.0).
BRANDS
Company details
- Company name
- Torrent Pharmaceuticals Limited
- NSE symbol
- TORNTPHARM
- BSE scrip code
- 500420
- ISIN
- INE685A01028
- Listed on
- NSE, BSE
- Series
- EQ (normal equity)
- Listed on NSE since
- 25 Nov 2002
- Face value
- ₹5 per share
- Market lot
- 1 share
- Shares issued
- 38.04 crore
- Index
- NIFTY 500
- Sector (NSE)
- Healthcare
- Industry
- Pharmaceuticals: Major
- Managing director / CEO
- Aman Mehta
- Chair
- Samir Mehta
- Headquarters
- Ahmedabad, Gujarat, India
- Registered address
- Avirat, Thaltej Shilaj Road, Ahmedabad - 380059
- Founded
- 1959
- Employees
- 20,341
- Financial year
- April to March
- Results basis
- Consolidated
- Website
- torrentpharma.com
Peers
Other Healthcare stocks
-
DIVISLABDivi's Laboratories
₹11,485.00
+1.04%
-
ALKEMAlkem Laboratories
₹5,302.00
-2.68%
-
GRANULESGranules India
₹840.50
+5.16%
-
SUNPHARMASun Pharmaceutical Industries
₹1,885.00
-0.91%
-
LAURUSLABSLaurus Labs
₹2,400.00
-1.19%
-
AUROPHARMAAurobindo Pharma
₹1,807.20
-1.11%
-
ACUTAASAcutaas Chemicals
₹3,996.10
+2.02%
-
APOLLOHOSPApollo Hospitals Enterprise
₹8,515.00
-1.03%
Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.